Plandaí Biotechnology, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PLPL research report →
Companywww.plandaibiotech.com
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis.
- CEO
- Roger Baylis-Duffield
- IPO
- 1995
- Employees
- 180
- HQ
- London, GB
Price Chart
Valuation
- Market Cap
- $448.89K
- P/E
- -5.91
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -5.91
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-2,446 · -100.02%
- EPS
- $0.00 · -100.00%
- Op Income
- $-57,446
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 9.73
- Avg Volume
- 18.05K
Get TickerSpark's AI analysis on PLPL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PLPL Coverage
We haven't published any research on PLPL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PLPL Report →